Attached files
| file | filename |
|---|---|
| EX-99.1 - ERBA Diagnostics, Inc. | v227763_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
_________________________________
Date of Report
July 5, 2011
(Date of earliest event reported)
IVAX Diagnostics, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
1-14798
(Commission File Number)
|
11-3500746
(IRS Employer Identification No.)
|
|
2140 North Miami Avenue
Miami, Florida
(Address of principal executive offices)
|
33127
(Zip Code)
|
(305) 324-2300
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On July 5, 2011, IVAX Diagnostics, Inc. issued a press release announcing that it has consummated the initial transactions contemplated by its previously announced stock purchase agreement, dated April 8, 2011, with ERBA Diagnostics Mannheim GmbH. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit 99.1 – Press Release dated July 5, 2011
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
IVAX DIAGNOSTICS, INC.
|
|||
|
Dated: July 5, 2011
|
By:
|
/s/ Kevin D. Clark | |
|
Kevin D. Clark,
|
|||
|
Chief Executive Officer,
|
|||
|
Chief Operating Officer and
President
|
|||
EXHIBIT INDEX
|
Exhibit
|
Description
|
|
99.1
|
Press Release dated July 5, 2011
|